BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 29397066)

  • 1. Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy.
    Liao Z; Tan ZW; Zhu P; Tan NS
    Cell Immunol; 2019 Sep; 343():103729. PubMed ID: 29397066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress.
    Chan JS; Tan MJ; Sng MK; Teo Z; Phua T; Choo CC; Li L; Zhu P; Tan NS
    Cell Death Dis; 2017 Jan; 8(1):e2562. PubMed ID: 28102840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
    Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
    Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miRNAs in cell signaling of cancer associated fibroblasts.
    Eichelmann AK; Matuszcak C; Hummel R; Haier J
    Int J Biochem Cell Biol; 2018 Aug; 101():94-102. PubMed ID: 29807095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.
    Wong KY; Cheung AH; Chen B; Chan WN; Yu J; Lo KW; Kang W; To KF
    Int J Cancer; 2022 Oct; 151(8):1195-1215. PubMed ID: 35603909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblasts in the Tumor Microenvironment: Shield or Spear?
    Alkasalias T; Moyano-Galceran L; Arsenian-Henriksson M; Lehti K
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29883428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer associated fibroblasts: is the force the path to the dark side?
    Barbazán J; Matic Vignjevic D
    Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.
    Ji X; Zhu X; Lu X
    Future Oncol; 2017 Jul; 13(17):1537-1550. PubMed ID: 28685611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
    Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
    Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.
    Ishii G; Ochiai A; Neri S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):186-196. PubMed ID: 26278673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells.
    Wang Z; Tan Y; Yu W; Zheng S; Zhang S; Sun L; Ding K
    Int J Biol Sci; 2017; 13(3):339-348. PubMed ID: 28367098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis.
    Erdogan B; Webb DJ
    Biochem Soc Trans; 2017 Feb; 45(1):229-236. PubMed ID: 28202677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.